We are live on ! Find out more
RC

Rangeley Capital Portfolio holdings

AUM $109M
1-Year Est. Return 97.13%
This Fund
S&P 500
This Quarter Est. Return
+28.51%
1 Year Est. Return
+97.13%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$116M
AUM Growth
+$31.8M
Cap. Flow
+$13.8M
Cap. Flow %
11.97%
Top 10 Hldgs %
43.17%
Holding
151
New
78
Increased
26
Reduced
12
Closed
24

Top Buys

Rank Stock Value
1
YEXT icon
Yext
YEXT
+$4.63M
2
TACO
Berto Acquisition Corp
TACO
+$3.29M
3
CCOI icon
Cogent Communications
CCOI
+$1.24M
4
LQDA icon
Liquidia Corp
LQDA
+$1.11M
5
ECHO
EchoStar
ECHO
+$1.04M

Top Sells

Rank Stock Value
1
SAGE
Sage Therapeutics
SAGE
+$6.66M
2
ITOS
iTeos Therapeutics
ITOS
+$3.01M
3
DK icon
Delek US
DK
+$2.79M
4
SKX
Skechers
SKX
+$2.27M
5
THRD
Third Harmonic Bio
THRD
+$1.57M

Sector Composition

Rank Sector Weight
1 Healthcare 32.16%
2 Miscellaneous 11.84%
3 Financials 11.03%
4 Energy 9.32%
5 Communication Services 8.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHF icon
51
Brighthouse Financial
BHF
$2.87B
$523K 0.45%
+9,850
New +$481K
FWRD icon
52
CALL
Forward Air
FWRD
$555M
$515K 0.45%
+20,100
New +$578K
ABVX
53
Abivax
ABVX
$10.2B
$509K 0.44%
+6,000
New +$368K
PCAP
54
ProCap Acquisition Corp
PCAP
$329M
$486K 0.42%
+47,304
New +$488K
DRDB
55
Roman DBDR Acquisition Corp II
DRDB
$327M
$446K 0.39%
+43,200
New +$444K
MGRM
56
DELISTED
Monogram Orthopaedics
MGRM
$440K 0.38%
+75,000
New +$401K
NBIS
57
Nebius Group N.V.
NBIS
$62.1B
$438K 0.38%
3,900
– –
OKUR
58
OnKure Therapeutics
OKUR
$127M
$428K 0.37%
155,490
+125,588
+420% +$311K
ODP
59
DELISTED
ODP
ODP
$427K 0.37%
+15,337
New +$315K
TDAY
60
USA Today Co
TDAY
$940M
$413K 0.36%
+100,000
New +$402K
GTERU
61
Globa Terra Acquisition Corp Units
GTERU
$159M
$411K 0.36%
+40,388
New +$410K
OACC
62
Oaktree Acquisition Corp III Life Sciences
OACC
$265M
$398K 0.34%
+37,827
New +$395K
VLOS
63
Velos Acquisition I Corp
VLOS
$382K 0.33%
+36,214
New +$387K
FDMT icon
64
4D Molecular Therapeutics
FDMT
$725M
$371K 0.32%
42,665
+29,665
+228% +$177K
LBTYK icon
65
Liberty Global Class C
LBTYK
$3.57B
$353K 0.31%
+30,000
New +$336K
CCIX
66
DELISTED
Churchill Capital Corp IX
CCIX
$348K 0.3%
+33,226
New +$350K
UNH icon
67
UnitedHealth
UNH
$338B
$345K 0.3%
+1,000
New +$302K
K
68
DELISTED
Kellanova
K
$328K 0.28%
4,000
+1,000
+33% +$79.5K
FERA
69
Fifth Era Acquisition Corp I
FERA
$315K 0.27%
+30,990
New +$315K
MLAC
70
DELISTED
Mountain Lake Acquisition Corp
MLAC
$309K 0.27%
+30,000
New +$308K
WW
71
WW International
WW
$153M
$301K 0.26%
+11,000
New +$378K
SRDX
72
DELISTED
Surmodics
SRDX
$299K 0.26%
+10,000
New +$334K
BRSL
73
Brightstar Lottery PLC
BRSL
$2B
$293K 0.25%
17,000
– –
NKTR icon
74
Nektar Therapeutics
NKTR
$2.37B
$279K 0.24%
+4,895
New +$162K
STAA icon
75
STAAR Surgical
STAA
$1.13B
$269K 0.23%
+10,000
New +$238K
1 2
3
4 5

Similar funds

GCM
Gumshoe Capital Management New York $109M AUM
SSCM
Seven Six Capital Management New York $110M AUM 1.79% 1-Year Est. Return
RCM
Revelation Capital Management Sausalito, California $110M AUM
BWM
Briggs Wealth Management Glastonbury, Connecticut $110M AUM
QFMHK
Q Fund Management (Hong Kong) Hong Kong $110M AUM 1,372.85% 1-Year Est. Return
AC
Amitell Capital Singapore $109M AUM 50.64% 1-Year Est. Return
ANBOT
American National Bank of Texas Richardson, Texas $110M AUM 17.16% 1-Year Est. Return
SCA
Sensenig Capital Advisors Collegeville, Pennsylvania $109M AUM

Rangeley Capital's Q3 2025 Portfolio in Review

As of Q3 2025, Rangeley Capital held 151 positions worth $116M, up 38% from $83.8M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Rangeley Capital deployed $13.8M of net new capital in Q3 2025, opening 78 new positions and adding to 26 existing holdings. Its largest new stake was Yext: 545,000 shares worth $4.64M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 47% a quarter earlier, followed by Miscellaneous and Financials.

On the sell side, the largest reduction was Delek US, an estimated $2.79M trimmed.

  • Rangeley Capital's largest Q3 2025 buy was Yext: 545,000 shares worth $4.64M.
  • Rangeley Capital added most to GSR III Acquisition Corp in Q3 2025, an estimated $941K increase.
  • Rangeley Capital's biggest Q3 2025 reduction was Delek US, cutting an estimated $2.79M.
  • Rangeley Capital fully exited Sage Therapeutics in Q3 2025, selling an estimated $6.66M.
  • Rangeley Capital's ten largest holdings make up 43% of its $116M portfolio in Q3 2025.
  • Rangeley Capital opened 78 new positions and closed 24 in Q3 2025.
  • Rangeley Capital's portfolio value rose 38% quarter-over-quarter to $116M.

Based on Rangeley Capital's 13F filing for Q3 2025, filed 14 Nov 2025.